Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Thomas Lingelbach
Hanneke Schuitemaker
Dipal Patel
Juan Carlos Jaramillo
Kendra Wergin
Peter Bühler
Petra Pesendorfer
Vincent Dequenne
Board:
Anne-Marie Graffin
Gerd Zettlmeissl
Kathrin Jansen
Danièle Guyot-Caparros
James Connolly
James Sulat
Maïlys Ferrère
Shareholding in %:
Amundi Austria GmbH 0.83
BPIFrance Participations SA /PRIVATE EQUITY/ 4.92
BlackRock Fund Advisors 0.88
CDC Croissance SA 2.71
Candriam Belgium SA 1.77
Deep Track Capital LP 4.03
Groupe Grimaud La Corbière SA 3.67
Norges Bank Investment Management 0.75
Pfizer Inc. 5.56
Polar Capital LLP 4.65
Freefloat 70.22
Address: Campus Bio-Ouest, 6, rue Alain Bombard, 44800 Saint-Herblain
T: +33-2-28-07-37-10
F: +
I: http://www.valneva.com
E: info@valneva.com